London, United Kingdom (CU)_ The UK’s most vulnerable hospital patients will now be able to access an experimental coronavirus medication that was administered to former US President Donald Trump to treat Covid 19. Ronapreve, which Mr Trump got while undergoing treatment for Covid-19 in a Washington-area hospital, could emerge as a breakthrough Covid 19 medication for the National Health Service. The antibody combination therapy resulted in a four-day reduction in hospital stays and a roughly 20% reduction in the chance of mortality.
According to the Department of Health and Social Care, Ronapreve is capable of…
